long-term effects of glp-1 medications Success GLP-1s Hinges on More Than Just a Prescription New Research on GLP-1s &

Protective benefits are evidenced in the liver, GI tract, cardiovascular system, and nervous system [6, 11, 25]

A study published in January 2022 linked Research published in December 2022 also reported the use of GLP-1 receptors was Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are a type of medication used to help manage type 2 diabetes

Semaglutide trials (STEP 1-4) demonstrated 15-22% weight loss over 68 weeks, while tirzepatide (SURMOUNT trials) showed 20-24% weight loss at the highest doses

Monitoring how your body responds to Eqvp GLP-1 is essential, and if any adverse reactions occur, it is best to discontinue use and seek professional advice